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Background: Hydrocarbon alkanes, components of major fossil fuels, are considered as next-generation biofuels
because their biological production has recently been shown to be possible. However, high-yield alkane production
requires robust host cells that are tolerant against alkanes, which exhibit cytotoxicity. In this study, we aimed to
improve alkane tolerance in Saccharomyces cerevisiae, a key industrial microbial host, by harnessing heterologous
transporters that potentially pump out alkanes.
Results: To this end, we attempted to exploit ABC transporters in Yarrowia lipolytica based on the observation that
it utilizes alkanes as a carbon source. We confirmed the increased transcription of ABC2 and ABC3 transporters
upon exposure to a range of alkanes in Y. lipolytica. We then showed that the heterologous expression of ABC2 and
ABC3 transporters significantly increased tolerance against decane and undecane in S. cerevisiae through
maintaining lower intracellular alkane level. In particular, ABC2 transporter increased the tolerance limit of S.
cerevisiae about 80-fold against decane. Furthermore, through site-directed mutagenesis for glutamate (E988 for
ABC2, and E989 for ABC3) and histidine (H1020 for ABC2, and H1021 for ABC3), we provided the evidence that
glutamate was essential for the activity of ABC2 and ABC3 transporters, with ATP most likely to be hydrolyzed by a
catalytic carboxylate mechanism.
Conclusions: Here, we demonstrated that transporter engineering through expression of heterologous efflux
pumps led to significantly improved tolerance against alkane biofuels in S. cerevisiae. We believe that our results laid
the groundwork for developing robust alkane-producing yeast cells through transporter engineering, which will
greatly aid in next-generation alkane biofuel production and recovery.
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The development of renewable biofuels such as bio-
ethanol [1], butanol [2], bio-diesel [3-5] and jetfuels [6]
helps to address energy security and climate change con-
cerns. Recently, the biological production of hydrocar-
bon alkanes, components of major fuels, has drawn
much attention because alkanes have high energy con-
tent and are compatible with existing transportation in-
frastructure. In addition, alkanes have been widely used
as an organic solvent in biochemical processes in an ef-
fort to improve substrate solubility, enzyme stability and* Correspondence: Matthewchang@ntu.edu.sg
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reproduction in any medium, provided the orspecificity [7,8]. In nature, alkanes are found to be pro-
duced from fatty acid metabolites in microorganisms
[9,10], insects [11] and plants [12]. Recently, an alkane
biosynthetic pathway was identified and characterized in
cyanobacteria and re-constructed in Escherichia coli
[10,13]. In addition, plant alkane biosynthesis pathway
was reconstituted in yeast [14].
Despite this promising potential of microbial alkane
production, yields and titers are key consideration for
industrial-scale production. Further, alkane biofuel pro-
duction can potentially be affected by the product toxicity
as alkanes are proven to be toxic to microorganisms
[15,16]. The toxicity of products can be evaluated based
on log Pow which represents the logarithm of partition
coefficients in n-octanol and water [17]. Organic productstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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microorganisms and other living cells, such as nonane
(logP OW = 5.5) and decane (logP OW = 6.0) [18]. These al-
kane products interact preferentially with cytoplasmic
membrane, therefore disorganizing its structural integrity.
Disruption of membrane structure impairs vital functions,
such as the loss of ions, metabolites, lipids, and proteins,
and the dissipation of the pH gradient and electrical po-
tential. In addition, several studies have shown that toler-
ance improvement can lead to clear increases in biofuel
production [19-21]. Consequently, there is an urgent need
to develop robust microbial cell factories that are tolerant
to alkane biofuels.
To overcome biofuel toxicity, several engineering strat-
egies have been designed. Alper et al. [19] employed a
global transcription machinery engineering (gTME) ap-
proach to improve ethanol tolerance. Stanley et al. [22]
used an adaptive evolution engineering method to select
stable ethanol-tolerant mutants of S. cerevisiae. Hou
et al. [23] developed novel genome shuffling method to
improve biofuel tolerance, whereas Kang et al. [24]
improved microbial tolerance to isooctane through iden-
tification and reconstitution of genetic regulatory net-
works. However, these classical tolerance-improving
strategies can be time consuming and laborious. Re-
cently, efflux pumps were utilized to alleviate product
toxicity and increase final productivity because of their
capability to pump out target products from cells
[21,25]. However, no attempts have been made to exploit
efflux pumps for alkane biofuel transport in S. cerevisiae,
a key biofuel cell factory. Hence, in this study, we fo-
cused on identifying efflux pumps that potentially trans-
port alkane biofuels and harnessing those pumps as a
direct mechanism for increasing tolerance through efflux
pumping of alkanes from cells.
To this end, we considered ATP-binding cassette
(ABC) transporters of Yarrowia lipolytica, an oleaginous
yeast that efficiently assimilates and utilizes hydrophobic
substrates such as alkanes, fatty acids and lipids [26-28].
Further, the mutants lacking part of ABC transporters
show defective phenotypes for alkane utilization as a car-
bon source [29,30]. Consequently, in this study, we
attempted to improve the tolerance of S. cerevisiae
against alkanes using Y. lipolytica ABC transporters.
Notably, we demonstrated that ABC2 and ABC3 trans-
porters maintained 5 and 30-fold lower intracellular dec-
ane and undecane levels respectively, and significantly
improved tolerance in S. cerevisiae, evidenced by about
80-fold increase in the tolerance limit against decane.
Results
Transcription activity of ABC transporters with alkanes
To assess whether ABC1, ABC2, ABC3 and/or ABC4 trans-
porters were involved in alkane transport in Y. lipolytica,we analysed the effects of alkanes with different chain
lengths (C8-C12) on the transcription levels of these
four ABC transporter genes using quantitative RT-PCR.
The reason that C8 to C12 alkanes were tested in this
study was that longer alkanes showed no toxicity toward
S. cerevisiae (data not shown). Compared with control
samples without alkane treatment, the transcription levels
of ABC1 and ABC4 showed no change when the cells
were treated with different alkanes (C8-C12) (Figure 1).
However, the mRNA levels of ABC2 were significantly
increased when Y. lipolytica was treated with octane
(C8), nonane (C9), decane (C10) and undecane (C11)
(p<0.05), while the mRNA levels of ABC3 were signifi-
cantly increased toward nonane (C9) and decane (C10)
(p<0.05) (Figure 1). These results strongly suggested that
two of the ABC transporters, ABC2 and ABC3, might play
a critical role in the transport of alkanes for C8, C9, C10
and C11 alkanes. Thus, based on the qRT-PCR results,
ABC2 and ABC3 were chosen for further analysis of their
alkane transport capability.
Expression and subcellular localization of ABC2 and ABC3
To confirm the expression of these two transporters in
S. cerevisiae, a 6x His tag was attached to the C terminus
of ABC2 and ABC3. Through immunodetection of 6x
His-tagged proteins, specific bands were assigned to
ABC2 (165 kDa) and ABC3 (167 kDa) (Figure 2A). This
western blot result confirmed the expression of ABC2
and ABC3 in S. cerevisiae. Next, to further analyse the
localization of ABC2 and ABC3, each of them was tagged
with EGFP at its C terminus. As shown in Figure 2B,
strong fluorescence was observed on the plasma mem-
brane of cells containing ABC2-EGFP and ABC3-EGFP
fusion proteins, respectively. These results suggest that
ABC2 and ABC3 were expressed and located on the
plasma membrane of S. cerevisiae.
To investigate whether EGFP would affect the local-
ization of the transporters, the functionality of ABC2- and
ABC3-EGFP was compared with that of ABC2 and ABC3.
This functionality was determined by the viability of the
cells in the presence of alkanes. The growth patterns of
strains expressing ABC2/3-EGFP fusion protein and
ABC2/3 were similar (data not shown). These data indi-
cate that EGFP fusion proteins function similarly as the
untagged proteins. Thus, EGFP tag does not affect the
localization of the transporter proteins.
ABC2 and ABC3 contribute to increasing alkane tolerance
After confirming that ABC2 and ABC3 were expressed
on the cell membrane, we conducted susceptibility assays
to study the effect of ABC2 and ABC3 on the tolerance
of the cells toward alkanes. The toxic effects of alkanes
on S. cerevisiae with ABC2 and ABC3 were measured








































































Figure 1 mRNA transcript levels of ABC1–4 genes in Y. lipolytica. Quantitative RT-PCR analyses of ABC1, ABC2, ABC3 and ABC4 in Y. lipolytica
cells upon treatment with octane, nonane, decane, undecane and dodecane (C8-C12). Each value of qRT-PCR was normalized to β-actin
expression levels and expressed as the fold change relative to the levels detected in control samples, which were cells without alkane treatment
and set equal to 1. Error bars represent the standard deviation (SD) of three biological replicates. Primers for qRT-PCR are listed in Table S1.
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cane were toxic to S. cerevisiae cells. However, in cells
expressing ABC2 and ABC3, cellular tolerance toward
decane and undecane was considerably improved. It was
observed that the expression of ABC2 led to higher
tolerance toward decane than ABC3. Note that ABC1
and ABC4 expression led to no tolerance improvement
(Additional file 1: Figure S1). Therefore, the results above
suggest that ABC2 and ABC3 successfully improved
alkane tolerance in S. cerevisiae.
To further examine quantitative effects of ABC2 and
ABC3 toward decane and undecane, alkane susceptibility
tests in liquid culture were conducted. As shown inFigure 3B, the tolerance limit of S. cerevisiae was below
0.50% and 20% for decane and undecane, respectively.
With ABC2 transporter, the tolerance limit was increased
to over 20% for both decane and undecane. With ABC3
transporter, the tolerance limit of S. cerevisiae was
improved to over 0.75% and 20% for decane and unde-
cane, respectively. This result suggests that the expression
of ABC2 and ABC3 transporters significantly improved
the tolerance toward decane and undecane.
To study the time-course behavior of ABC2- and
ABC3-expresssing S. cerevisiae cells in the presence of
0.5% decane and 20% undecane, which caused no growth
in the wild-type cells, the growth patterns were studied.
Figure 2 Expression and subcellular localization of ABC2 and ABC3. (A) Expression of ABC2 and ABC3. The expression of ABC2 and ABC3
carrying 6xHis tag was confirmed by western blot analysis. The positions of molecular mass markers are indicated at left. Western blot analyses
were performed as described under “Methods”. (B) Subcellular localization of ABC2 and ABC3 determined by fluorescence microscopy. Yeast cells
carrying plasmids encoding ABC2-EGFP or ABC3-EGFP fusion proteins were cultured and harvested. Phase contrast figures and fluorescence
figures are shown.
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the transporters exhibited no growth, the cells with ABC2
and ABC3 transporters grew normally after initial growth
delays. ABC3 expressing cells underwent a longer growth
delay under both alkane treatments, but exhibited a
slightly higher growth rate with decane treatment. Note
that S. cerevisiae cells expressing ABC2 and ABC3 trans-
porters exhibited similar growth rates in the absence of
alkanes (Figure 3C, Additional file 1: Table S2).
ABC2 and ABC3-mediated efflux pumping of alkanes
The results of susceptibility assay on agar plates and in
liquid medium showed that both ABC2 and ABC3 trans-
porters greatly enhanced tolerance toward decane and
undecane, with ABC2 leading to stronger tolerance. We
therefore hypothesized that the tolerance generated by
ABC2 and ABC3 was linked to the efflux pumping of
decane and undecane. Alkane efflux pumping might
help to maintain an intracellular alkane concentration
under a toxic threshold.
To verify this hypothesis, intracellular alkane accumu-
lation was analysed after 48 h incubation with 0.5% dec-
ane or 20% undecane. As shown in Figure 4, cells
expressing ABC2 and ABC3 had ~5-fold lower intracel-
lular decane level relative to the control. Further, ABC2
and ABC3 transporters were shown to reduce the intra-
cellular undecane level approximately 30-fold compared
to the control. The sharp decrease in intracellular alkane
levels strongly suggests that ABC2 and ABC3 function
as decane and undecane efflux pumps.
Glutamate is required for energy-dependent efflux
pumping of ABC2 and ABC3
The main characteristic of ABC transporters is that ABC
transporters utilize the energy of ATP hydrolysis to carryout biological processes. The ATP hydrolysis model is
essential for ABC transporters. Thus, to better under-
stand ABC2 and ABC3’s mechanisms in alkane export,
we looked into the possible ATP hydrolysis models for
both transporters. Two different models of ATP hydroly-
sis mechanisms were proposed for ABC transporters be-
fore: the “catalytic carboxylate” model [31] and the
“catalytic dyad” model [32]. According to the “catalytic
carboxylate” model, the highly conserved glutamate resi-
due at the C terminus of the Walker B motif is essential
for ATP hydrolysis. However, in the “catalytic dyad”
model, interactions between glutamate of the Walker B
motif and the histidine of the H-loop are a prerequisite
for ATP hydrolysis.
Protein analyses revealed four possible locations of
characteristic domains in ABC transporters, namely two
nucleotide-binding domains (NBD1 & 2) and two trans-
membrane domains (TMD1 & 2) [33,34]. Sequence
alignment of ABC2, ABC3, PDR5 and PDR15 showed
that these proteins have high similarities in NBD
domains which include Walker A motif, Walker B motif,
C-loop and H-loop (Figure 5A). Similar to the widely
studied PDR5 model [33,34], critical amino acids such as
glutamate in C-terminus of Walker B motif and histidine
of H-loop are only present in NBD2 but not in NBD1
for ABC2 and ABC3 [35].
Hence, to determine the ATP hydrolysis mechanism
of ABC2 and ABC3, the glutamate (E988 for ABC2
and E989 for ABC3) and the histidine (H1020 for
ABC2 and H1021 for ABC3) in NBD2 of ABC2 and
ABC3 were mutated to glutamine and alanine, re-
spectively (Additional file 1: Figure S2). As shown
in Figure 5B, ABC2-E988Q and ABC3-E989Q mutants
were highly sensitive against both decane and un-
decane, while ABC2-H1020A and ABC3-H1021A
0.25%
0.50%
























































Figure 3 Alkane susceptibility assay for S. cerevisiae. Alkane susceptibility assays were performed in S. cerevisiae cells expressing ABC2, ABC3
or with an empty plasmid. (A) Alkane susceptibility assay on agar plates. Serial 10-fold dilutions (from left to right: non diluted, 10-1, 10-2, 10-3) of
cells were spotted on agar plates with alkanes (octane, nonane, decane, undecane and dodecane) as vapor phase. Plates were incubated at 28°C
for 2 days. (B) Alkane susceptibility assay in liquid culture. Overnight cell culture was diluted into induction medium (final OD600=0.4) with alkanes
(decane or undecane). The cell culture was incubated for 48 h at 28°C. The OD600 value of each sample was determined and plotted against its
corresponding alkane concentration (0.1%, 0.25%, 0.5%, 0.75%, 1%, 2%, 5%, 10% and 20% vol/vol). Each point represents the mean of three
biological replicates; standard deviations are presented. Arrows indicate increased cell tolerance towards alkanes. (C) Growth file of cells in alkane-
inhibiting conditions (0.5% (vol/vol) decane or 20% (vol/vol) undecane). Symbols for strains are: control sample with empty plasmid (open circle),
cells expressing ABC2 (filled circle), cell expressing ABC3 (filled triangle).
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cane. Therefore, histidine is deemed not as essential
as glutamate for these transporters’ activity, and ATP
is most likely to be hydrolyzed by the catalytic carb-
oxylate mechanism.Discussion
In biofuel production, end products such as alkanes
are frequently toxic to host cells, thereby placing a
limit on the yield. Thus, cellular tolerance optimization





























Figure 4 Intracellular alkane levels of ABC2 and ABC3. S.
cerevisiae BY4741 with and without ABC2/3 were cultured
under exposure to 0.5% (vol/vol) alkane or 20% (vol/vol)
undecane. After 48 h incubation, intracellular alkane levels were
measured as described under “Methods”. Intracellular alkane levels
were normalized to that of control cells carrying an empty plasmid.
Data shown are the mean ± SD of four biological replicates.
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cluding increasing tolerance toward biofuels in produ-
cing host cells, need to be developed. To this end,
here, we focused on improving alkane tolerance in S.
cerevisiae. Our alkane susceptibility assays revealed
that C12 or longer alkanes exhibited little or no tox-
icity toward S. cerevisiae (data not shown), while C8-
C11 alkanes were toxic. This result suggests that
longer chain length alkanes have lower cell toxicity to-
ward S. cerevisiae, in agreement with the previous
study by Gill and Ratledge (1972) [15] demonstrating
that the toxicity of alkanes is related to their chain
length. The proposed mechanisms for this
phenomenon are as follows. First, higher chain lengths
lead to increasing molecular weight. The higher the
molecular weight is, the harder it is for the compound
to penetrate yeast cell membrane. Second, a previous
study [18] suggested that a compound whose log Pow
is between 1.5 and 6.0 is considered extremely toxic to
microorganisms and other living cells, such as nonane
(log Pow = 5.5) and decane (log Pow = 6.0). Higher
chain length alkanes have higher log Pow value. For ex-
ample, C12 alkane has log Pow of 7.0 and alkanes with
chain length above 12 have higher log Pow. This
reported correlation between toxicity and log Pow is in
line with our observation that alkanes with longer
chain length (C12 or longer) show insignificant toxicity
toward S. cerevisiae. Since longer alkanes showed in-
significant toxicity toward S. cerevisiae, this study wasfocused on improving the tolerance of S. cerevisiae
against alkanes with C12 and below.
ABC2 and ABC3 were selected as candidates based on
their potentials toward alkane efflux pumping. Although
both ABC2 and ABC3 expressing cells showed increased
C10 and C11 alkane tolerance, ABC2 exhibited better
performance than ABC3, suggesting that ABC2 is a
more effective pump for alkane transport. Thus, we
looked into the possible reasons for the difference in ef-
ficiency between these two transporters. One plausible
reason is the difference in kinetics of substrate–protein
interactions and/or nucleotide–protein interactions be-
tween ABC2 and ABC3. For example, Low et al. (2010)
[36] found that difference in TMD residues can lead to
differences in ABC transporter efficiency. It was
hypothesized that the TMD residues might affect sub-
strate affinity, resulting in differences in substrate-
protein kinetics. Another reason for the different efflux
efficiencies may be post-translational modification pat-
terns. Protein phosphorylation was found to be essential
for the stability of the yeast multidrug transporter Pdr5p
[37]. As hypothesized before, transporters, such as
Pdh1p that requires more phosphorylations than Cdr1p,
may take longer time to reach its active, substrate-
effluxing form [38]. Thus, similar to Pdh1p, it is possible
that ABC3 requires longer phosphorylation time to ar-
rive at its active alkane-effluxing form.
Besides the difference in efflux pumping efficiencies of
ABC 2 and ABC3, we also observed that ABC2 and
ABC3 did not increase tolerance toward shorter chain
alkanes such as C8 and C9. Future work therefore may
include directed evolution of these transporters to
broaden their substrate specificity, mainly toward
shorter chain alkanes. For example, random mutagenesis
was shown to affect substrate specificity of ABC trans-
porters [39]. Also, protein structure studies may be
needed for better understanding of the exact substrate
binding and transport mechanism.
Conclusions
In this study, we demonstrated that transporter engin-
eering through expression of heterologous efflux pumps
led to improved tolerance against alkanes in S. cerevisiae,
a key industrial microbial host. In particular, we showed
that the tolerance limit of S. cerevisiae was increased
about 80-fold against decane. Further, we provided the
evidence that the improved tolerance was primarily due
to the lowering of the intracellular alkane level wherein
ABC2 and ABC3 function as an efflux pump. To our
knowledge, this is the first study to harness a
transporter-engineering strategy for alkane tolerance im-
provement in eukaryotic host cells, which is readily ap-
plicable to alkane biofuel-producing microbes. We
believe that our work here laid the groundwork for
Figure 5 Transporter sequence comparison and alkane susceptibility assay of ABC2 and ABC3 mutants. (A) Multiple sequence alignment
of NBD2 of ABC transporters. ABC2 [GenBank: CAG82364]; ABC3 [GenBank: CAG82646]; PDR5 [GenBank: CAA99359]; and PDR15 [GenBank:
AAB64846]. Starting amino acid numbers are shown in each line. Sequences were aligned in ClustalW, and the shading was created by Mobyle
Pasteur Boxshade. Single letter abbreviations for amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys;
L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr. (B) Alkane susceptibility assay with ABC2 and ABC3 mutants.
Susceptibility assays were performed as described under “Methods”.
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transporter engineering, which will greatly aid in next-
generation alkane biofuel production and recovery.
Methods
Strains and media
All cells involved in cloning experiments were E. coli
TOP10 (Invitrogen) unless otherwise stated. Luria-
Bertani (BD) was used as the medium for cloning studies
unless otherwise stated. Ampicillin (100 μg/ml) was
added to the culture media for antibiotic selection where
appropriate.
The yeast strains S. cerevisiae BY4741 (ATCC 201388)
and Y. lipolytica CLIB122 (CIRM) were used for func-
tion characterization. S. cerevisiae BY4741 was cultured
in rich medium (YPD), synthetic minimal medium lack-
ing uracil (SC-U) or induction medium. YPD medium
(1% yeast extract, 2% peptone and 2% D-glucose) was
used to routinely maintain wild type strain. SC-U
medium (0.67% yeast nitrogen base, 0.192% uracil drop-
out and 2% raffinose) was used for growing pYES2 trans-
formants. Induction medium (0.67% yeast nitrogen base,
0.192% uracil dropout, 1% raffinose and 2% galactose)was used for protein induction in S. cerevisiae cells.
Medium containing 0.67% yeast nitrogen base supple-
mented with 0.5% casein hydrolysate and 2% glucose
was used for growth of Y. lipolytica for qRT-PCR sample
preparation. Solid media were supplemented with 2%
agar. Yeast growth media components were purchased
from Sigma-Aldrich.
Alkanes (octane (C8), nonane (C9), decane (C10),
undecane (C11) and dodecane (C12)) purchased from
Sigma-Aldrich were added to culture media for protein
function analysis where appropriate.
Plasmid construction
A list of the oligonucleotides used is shown in Additional
file 1: Table S1. Plasmid pYES2 (Invitrogen) with the
GAL1 promoter was used as an expression vector.
To clone 6x His-tagged ABC2, genomic DNA of Y.
lipolytica CLIB122 was used as a PCR template with two
pairs of primers ABC2-F1/ABC2-R1, and ABC2-F2
/ABC2-R2. The two PCR products were combined
through the Splicing Overlap Extension (SOE) method
[40] using flanking primers ABC2-F1 and ABC2-R2. The
resulting DNA fragment was digested with HindIII and
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tion enzymes, creating pYES2ABC2. Plasmid pYE-
S2ABC3 was constructed as for pYES2ABC2. Site-
directed mutagenesis of the transporters ABC2-E988Q,
ABC2-H1020A, ABC3-E989Q and ABC3-H1021A were
constructed by mutating glutamate to glutamine and
histidine to alanine respectively.
Plasmid pYES2ABC2-EGFP, which encodes yeast
enhanced green fluorescent protein (EGFP) at the C-
terminus of the ABC2 open reading frame, was con-
structed as follows. We used pYES2ABC2 as a PCR tem-
plate with primer set ABC2-F1 and ABC2-EGFP-R2.
The resulting DNA fragment was digested with HindIII
and NotI and cloned into pYES2 cut with the same re-
striction enzymes, creating pYES2ABC2-1. EGFP was
amplified from pKT127 (Euroscarf ) [41] using primer
set EGFP-F and EGFP-R, digested with NotI and SphI
and inserted into the same restriction sites of
pYES2ABC2-1 to create pYES2ABC2-EGFP. Plasmid
pYES2ABC3-EGFP was constructed as for pYES2ABC2-
EGFP. For construction of pYES2EGFP, EGFP was amp-
lified by PCR from pKT127 using primers EGFP-control
-F and EGFP-R, digested with NotI and SphI and cloned
into pYES2. All restriction and ligation enzymes were
purchased from New England Biolabs (NEB).
Quantitative RT-PCR
Total RNA samples from Y. lipolytica CLIB122 cells,
which were treated and untreated with alkane for 24 h,
were prepared using RNeasy Mini Kit (Qiagen), followed
by cDNA synthesis using H minus Reverse transcriptase
kit (Fermentas). Quantitative RT-PCR analysis was per-
formed on the Bio-Rad iQ5 real-time PCR detection sys-
tem using SsoFast EvaGreen Supermix kit (Bio-Rad).
The actin gene (YALI0D08272g) [42] was used as refer-
ence gene for Y. lipolytica. Relative mRNA levels were
derived using comparative CT method. PCR primer
sequences are listed in Additional file 1: Table S1.
Western blot analysis
S. cerevisiae cells carrying the plasmids encoding the 6x
His-tagged ABC2 and ABC3 were cultured in induction
medium and harvested at OD600=1-2 (early exponential
phase). The protein extraction method here is based on
alkaline lysis [43] and glass bead lysis [44] methods. The
following handling process was carried out in the cold
room (~4°C). Cell pellets (around 14 mg) were re-
suspended in 300 μl cold lysis buffer (0.1 M NaOH, 2%
β-mercaptoethanol, and protease inhibitor mixture
(Roche Applied Science)). After 5 min, glass beads (425-
600 μm, Sigma) were added to the suspension. The cells
were lysed by vortexing for 2 min. The lysate obtained
was clarified by transferring supernatant into a new tube.
Proteins in the lysate were fully dissolved by adding SDS(final concentration around 2%) and gently stirring for
10 min. After centrifugation, the supernatant was mixed
equally with Laemmli sample buffer (Bio-Rad) and sepa-
rated on a SDS-polyacrylamide gel. The sample gels
were used for blotting. Proteins were blotted onto a
0.2 μm nitrocellulose membrane (Bio-Rad) through
Trans-Blot Turbo Blotting System (Bio-Rad). 6x His-
tagged ABC2 and ABC3 were detected using anti-6x
His-tag antibody (HRP) (ab1187, Abcam) and 3,30,5,50-
Tetramethylbenzidine (TMB) liquid substrate system
(Sigma).
Fluorescence microscopy
S. cerevisiae BY4741 cells carrying plasmid pYES2ABC2-
EGFP or pYES2ABC3-EGFP were grown to the early ex-
ponential phase in induction medium, harvested and
mounted on the poly-L-lysine-coated slide glass. EGFP
fluorescence was analysed with a fluorescent microscope
(Zeiss Axio Scope A1).
Alkane susceptibility assays
Alkane susceptibility test on agar plate: Alkane suscepti-
bility test on plates was performed according to the
methods of Mauersberger et al. [28,29]. Exponentially
growing cells in induction medium were centrifuged and
re-suspended until OD600 reaches 1. Ten microliter ali-
quots of successive 10-fold dilutions (non diluted, 10-1,
10-2, 10-3) of the cells were spotted onto the induction
medium plate. Alkanes were supplied as vapour phase
by placing 200 μl alkane on a sterile filter paper in the
lid of the petri dish. Plates were incubated at 28°C for
2 days.
Alkane susceptibility test in liquid culture: Overnight
cultures were diluted into 5 ml induction medium in
50 ml glass bottle (Sigma) at an initial OD600 of 0.4.
Alkanes were added at different final concentrations.
Bottles were sealed tightly with butyl rubber stopper
(Sigma) and silver aluminum seal (Sigma). Liquid culture
was performed at 28°C with shaking. Growth was moni-
tored by measuring the OD600 at different time points.
Cell cultures used for time point OD600 checking were
collected from the glass bottle using needles and
syringes.
Determination of intracellular alkane levels
After induction for 48 h with or without addition of
alkanes, S. cerevisiae cells transformed with pYES2, pYE-
S2ABC2 and pYES2ABC3 were harvested at 6000 g for
5 min at 4°C. After washing with 50 mM Tris.Cl, the
cells were equally divided into two parts, one part for
intracellular alkane extraction and the other for deter-
mination of total protein content. For alkane extraction,
cell pellets were re-suspended in freshly prepared HPLC
grade Chloroform/Methanol (v/v, 2:1). Dodecane was
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washed glass beads were added until the suspension was
covered. Cells were then lysed by mechanical agitation
using FastPrep-24 (MPBio) for 6 min at 6 m/s. The
crude extract was obtained by pipettes. After addition of
autoclaved ddH2O, the crude extract was emulsified for
10 min by inversion. After centrifugation, the crude ex-
tract was separated into two phases. The bottom phase
containing alkane was transferred into a new 1.5 ml
microcentrifuge tube and purified as above with chloro-
form and ddH2O until particulate matter was no longer
observed. The purified solution was transferred into a
clear GC vial for GC analysis. To check the total protein
content, the cell pellets were re-suspended into 50 mM
Tris.Cl and lysed via mechanical agitation with acid-
washed glass beads. Protein content of obtained crude
extract was determined using the Bradford protein assay
(Bio-Rad). Intracellular alkane levels were normalized to
internal standard and cell lysate protein content [45,46].
Additional file
Additional file 1: Table S1. Primers used in this study. Restriction sites
are bold. Table S2. Specific growth rates under C10 and C11 alkane
treatments. Figure S1. Alkane susceptibility assay with ABC1 and ABC4.
Serial 10-fold dilutions (from left to right: non diluted, 10-1, 10-2, 10-3) of
cells were spotted on agar plates with alkanes (octane, nonane, decane,
undecane and dodecane) as vapor phase. Figure S2. To gengerate a
topology model of ABC2 (A) and ABC3 (B), the TMHMMfix algorithm was
used (http://www.sbc.su.se/~melen/TMHMMfix/). the resulting model was
visualized by the TOPO2 transmembrane protein display software
(http://www.sacs.ucsf.edu/cgi-bin/open-topo2.py). The Walker A motifs
are shown in blue, the Walker B motifs are shown in green, and the
C-loop are shown in orange. Residues that were mutated in this study
are shown in red.
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